Core Points - Work Medical Technology Group Ltd. experienced a significant stock surge of 50.26% in after-hours trading following a 9.19% gain during the regular session, closing at $3.92 [1][2][6] - The company announced a $1 million investment in Neologics Bioscience Inc., acquiring a 10% equity stake, which will increase Neologics' capital reserve to $10 million [2][3] - The investment agreement grants Work Medical corporate governance privileges, including board member nominations and first refusal rights on future equity sales [3][4] Stock Split and Compliance - A 1-for-100 reverse stock split was executed on October 16, reducing the number of outstanding Class A ordinary shares from approximately 96 million to 960,000 to comply with Nasdaq's minimum bid price requirements [4][5] - The reverse stock split was approved by shareholders and the board, aimed at regaining compliance with Nasdaq Marketplace Rule 5550(a)(2) [5] Stock Performance Overview - Work Medical's stock is trading near its 52-week low of $3.50, reflecting a substantial 99.35% loss over the past year, with a market capitalization of $364.46 million and an average daily trading volume of 344,000 shares [6]